Seqens launches HPAPI manufacturing at 100-year-old site
The global pharmaceutical ingredient producer has opened a high-potency active pharmaceutical ingredient unit at its century-old facility in France.
Archives for September 14, 2020
Clinical Ink: demands of CNS studies call for advanced data solutions
A leader from the clinical trial technology firm shares how direct data capture and other solutions can address the unique needs of such complex studies.
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Merck and Seattle Genetics have announced two strategic oncology collaborations: one to develop Seattle Genetics’ antibody-drug conjugate ladiratuzumab vedotin worldwide; and another to accelerate the global reach of Tukysa (tucatinib).
Elevating Effective Outcomes with Companion Diagnostics
Paid for and content provided by Q² Solutions
Companion diagnostics (CDx) is a keystone for pharma to create more precise drug therapies as personalized medicine accelerates. Here’s why a CDx central laboratory partner is necessary.